The DOI matches its Crossref record; 297 of the 297 references it cites were found in a registry or an index.
Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function
Open accessAbstract
Huntington’s disease (HD) is a progressive, fatal neurological condition caused by an expansion of CAG (glutamine) repeats in the coding region of the Huntington gene. To date, there is no cure but great strides have been made to understand pathophysiological mechanisms. In particular, genetic animal models of HD have been instrumental in elucidating the progression of behavioral and physiological alterations, which had not been possible using classic neurotoxin models. Our groups have pioneered the use of transgenic HD mice to examine the excitotoxicity hypothesis of striatal neuronal dysfunction and degeneration, as well as alterations in excitation and inhibition in striatum and cerebral cortex. In this review, we focus on synaptic and receptor alterations of striatal medium-sized spiny (MSNs) and cortical pyramidal neurons in genetic HD mouse models. We demonstrate a complex series of alterations that are region-specific and time-dependent. In particular, many changes are bidirectional depending on the degree of disease progression, i.e., early versus late, and also on the region examined. Early synaptic dysfunction is manifested by dysregulated glutamate release in striatum followed by progressive disconnection between cortex and striatum. The differential effects of altered glutamate release on MSNs originating the direct and indirect pathways is also elucidated, with the unexpected finding that cells of the direct striatal pathway are involved early in the course of the disease. In addition, we review evidence for early N-methyl-D-aspartate receptor (NMDAR) dysfunction leading to enhanced sensitivity of extrasynaptic receptors and a critical role of GluN2B subunits. Some of the alterations in late HD could be compensatory mechanisms designed to cope with early synaptic and receptor dysfunctions. The main findings indicate that HD treatments need to be designed according to the stage of disease progression and should consider regional differences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–297 of 297
Activity-dependent NMDA receptor degradation mediated by retrotranslocation and ubiquitination
Kato, A., Rouach, N., Nicoll, R. A., & Bredt, D. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501769102 · Cited by 154
Richfield, E. K., Maguire‐Zeiss, K. A., Vonkeman, H. E., & Voorn, P. (1995) · Annals of Neurology · doi:10.1002/ana.410380605 · Cited by 153
Earliest functional declines in Huntington disease
Beglinger, L. J., O’Rourke, J. J. F., Wang, C., Langbehn, D. R., Duff, K., & Paulsen, J. S. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.04.030 · Cited by 147
Oliveira, J. M. A., Chen, S., Almeida, S., Riley, R. R., Gonçalves, J., Oliveira, C. R., Hayden, M. R., Nicholls, D. G., Ellerby, L., & Rego, A. C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3004-06.2006 · Cited by 147
Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease
Johnson, M. A., Rajan, V., Miller, C. E., & Wightman, R. M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03762.x · Cited by 146
Zhang, H., Li, Q., Graham, R. K., Slow, E., Hayden, M. R., & Борисович, Б. И. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.03.010 · Cited by 144
Standaert, D. G., Friberg, I. K., Landwehrmeyer, G. B., Young, A. B., & Penney, J. B. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00293-9 · Cited by 143
Differential Electrophysiological Changes in Striatal Output Neurons in Huntington's Disease
André, V. M., Cepeda, C., Fisher, Y. E., Huynh, M. N., Bardakjian, N., Singh, S., Yang, X. W., & Levine, M. S. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3539-10.2011 · Cited by 142
Self-citationMorton, A. J., Lagan, M., Skepper, J. N., & Dunnett, S. B. (2000) · Journal of Neurocytology · doi:10.1023/a:1010887421592 · Cited by 138
Synaptic plasticity: one STEP at a time
Braithwaite, S. P., Paul, S., Nairn, A. C., & Lombroso, P. J. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.06.007 · Cited by 138
Chemical Pathology of Huntington's Disease
Bird, E. D. (1980) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.20.040180.002533 · Cited by 138
Shehadeh, J., Fernandes, H. B., Mullins, M. Z., Graham, R. K., Leavitt, B. R., Hayden, M. R., & Raymond, L. A. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.001 · Cited by 136
Self-citationFan, M., Fernandes, H. B., Zhang, L. Y. J., Hayden, M. R., & Raymond, L. A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4356-06.2007 · Cited by 134
Self-citationDecrease in Striatal Enkephalin mRNA in Mouse Models of Huntington’s Disease
Menalled, L., Zanjani, H., Mackenzie, L., Koppel, A. B., Carpenter, E. M., Zeitlin, S., & Chesselet, M. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7327 · Cited by 133
Gu, X., André, V. M., Cepeda, C., Li, S., Li, X., Levine, M. S., & Yang, X. W. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-8 · Cited by 132
Self-citationHeng, M. Y., Detloff, P. J., Wang, P. L., Tsien, J. Z., & Albin, R. L. (2008) · Nature Precedings · doi:10.1523/jneurosci.5599-08.2009 · Cited by 131
Miller, B., Walker, A. G., Shah, A. S., Barton, S. J., & Rebec, G. V. (2008) · Journal of Neurophysiology · doi:10.1152/jn.90606.2008 · Cited by 131
Kim, M.-J., Jo, D., Hong, G.-S., Kim, B. J., Lai, M. M.-S., Cho, D.-H., Kim, K. W., Bandyopadhyay, A., Hong, Y., Kim, D. H., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152336999 · Cited by 130
Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease
Li, L., Fan, M., Icton, C. D., Chen, N., Leavitt, B. R., Hayden, M. R., Murphy, T. H., & Raymond, L. A. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.04.003 · Cited by 128
Self-citationGraham, R. K., Pouladi, M. A., Joshi, P. R., Lu, G., Deng, Y., Wu, N., Figueroa, B. E., Metzler, M., André, V. M., Slow, E., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5473-08.2009 · Cited by 127
Self-citationCummings, D. M., Milnerwood, A. J., Dallérac, G. M., Waights, V., Brown, J. Y., Vatsavayai, S. C., Hirst, M. C., & Murphy, K. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl224 · Cited by 127
Self-citationMilnerwood, A. J., & Raymond, L. A. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.142448 · Cited by 126
Self-citationSpecific proteolysis of the NR2 subunit at multiple sites by calpain
Guttmann, R. P., Baker, D. L., Seifert, K. M., Cohen, A. S., Coulter, D. A., & Lynch, D. R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00493.x · Cited by 123
The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease
Hickey, M. A., Reynolds, G. P., & Morton, A. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00804.x · Cited by 122
Functional imaging in Huntington's disease
Paulsen, J. S. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2008.12.015 · Cited by 120
Cao, J., Semenova, M. M., Solovyan, V. T., Han, J., Coffey, E. T., & Courtney, M. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402353200 · Cited by 119
Uhl, G. R., NAVIA, B. A., & Douglas, J. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-12-04755.1988 · Cited by 118
Increased GABAergic function in mouse models of Huntington's disease: Reversal by BDNF
Cepeda, C., Starling, A. J., Wu, N., Nguyen, O. K., Uzgil, B., Soda, T., André, V. M., Ariano, M. A., & Levine, M. S. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20344 · Cited by 118
Self-citationFan, J., Cowan, C. M., Zhang, L. Y. J., Hayden, M. R., & Raymond, L. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2491-09.2009 · Cited by 117
Self-citationAltered palmitoylation and neuropathological deficits in mice lacking HIP14
Singaraja, R. R., Huang, K., Sanders, S. S., Milnerwood, A. J., Hines, R. M., Lerch, J. P., Franciosi, S., Drisdel, R. C., Vaid, K., Young, F. B. J., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr308 · Cited by 117
Self-citationHuang, K., Kang, M. H., Askew, C. E., Kang, R., Sanders, S. S., Wan, J., Davis, N. G., & Hayden, M. R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.027 · Cited by 116
Panov, A. V., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00585-4 · Cited by 116
Striatal Potassium Channel Dysfunction in Huntington's Disease Transgenic Mice
Ariano, M. A., Cepeda, C., Calvert, C. R., Flores‐Hernández, J., Hernández, E., Klapstein, G. J., Chandler, S. H., D, N. A. M., DiFiglia, M., & Levine, M. S. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00791.2004 · Cited by 113
Self-citationLi, L., Murphy, T. H., Hayden, M. R., & Raymond, L. A. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00308.2004 · Cited by 106
Self-citationLuthi-Carter, R., Apostol, B. L., Dunah, A. W., DeJohn, M. M., Farrell, L. A., Bates, G. P., Young, A. B., Standaert, D. G., Thompson, L. M., & Cha, J.-H. J. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.024 · Cited by 104
Rigby, M., Bourdellès, B. L., HEAVENS, R. P., Kelly, S., Smith, D. W., Butler, A., Hammans, R., Hills, R., Xuereb, J. H., Hill, R. G., et al. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00089-9 · Cited by 103
Genetic Mouse Models of Huntington’s Disease: Focus on Electrophysiological Mechanisms
Cepeda, C., Cummings, D. M., André, V., Holley, S. M., & Levine, M. S. (2010) · ASN NEURO · doi:10.1042/an20090058 · Cited by 101
Self-citationBallion, B., Mallet, N. P., Bézard, E., Lanciego, J. L., & Gonon, F. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06192.x · Cited by 100
André, V. M., Cepeda, C., Cummings, D. M., Jocoy, E. L., Fisher, Y. E., Yang, X. W., & Levine, M. S. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07047.x · Cited by 100
Self-citationStarling, A. J., André, V. M., Cepeda, C., de Lima, M., Chandler, S. H., & Levine, M. S. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20651 · Cited by 99
Self-citationHeinsen, H., Rüb, U., Gangnus, D., Jungkunz, G., Bauer, M., Ulmar, G., Bethke, B., Schüler, M., Böcker, F. M., Eisenmenger, W., et al. (1996) · Acta Neuropathologica · doi:10.1007/s004010050408 · Cited by 97
Fan, J., Gladding, C. M., Wang, L., Zhang, L. Y. J., Kaufman, A. M., Milnerwood, A. J., & Raymond, L. A. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.019 · Cited by 96
Self-citationStriatal neurochemical changes in transgenic models of Huntington's disease
Ariano, M. A., D, N. A. M., DiFiglia, M., Tagle, D. A., Sibley, D. R., Leavitt, B. R., Hayden, M. R., & Levine, M. S. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10272 · Cited by 96
Self-citationRegulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington's mouse model
Jarabek, B. R., Yasuda, R. P., & Wolfe, B. B. (2003) · Brain · doi:10.1093/brain/awh058 · Cited by 96
Brusa, L., Orlacchio, A., Moschella, V., Iani, C., Bernardi, G., & Mercuri, N. B. (2008) · Movement Disorders · doi:10.1002/mds.22376 · Cited by 93
Spampanato, J. G., Gu, X., Yang, X. W., & Módy, I. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.09.020 · Cited by 93
Rosas, H. D., Feigin, A., & Hersch, S. M. (2004) · Neurotherapeutics · doi:10.1602/neurorx.1.2.263 · Cited by 93
Dopamine and cognitive functioning: Brain imaging findings in Huntington’s disease and normal aging
Bäckman, L., & Farde, L. (2001) · Scandinavian Journal of Psychology · doi:10.1111/1467-9450.00238 · Cited by 92
Altered Information Processing in the Prefrontal Cortex of Huntington's Disease Mouse Models
Walker, A. G., Miller, B., Fritsch, J. N., Barton, S. J., & Rebec, G. V. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2804-08.2008 · Cited by 90
Picconi, B., Passino, E., Sgobio, C., Bonsi, P., Barone, I., Ghiglieri, V., Pisani, A., Bernardi, G., Ammassari‐Teule, M., & Calabresi, P. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.10.009 · Cited by 90
Ion Channel Clustering by Membrane-associated Guanylate Kinases
El-Husseini, A., Topinka, J. R., Lehrer‐Graiwer, J., Firestein, B. L., Craven, S. E., Aoki, C. J., & Bredt, D. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909919199 · Cited by 89
Huntington Disease in Children: Genotype-Phenotype Correlation
Rasmussen, A., Macias, R., Yescas, P., Ochoa, A., Davila, G., & Alonso, E. (2000) · Neuropediatrics · doi:10.1055/s-2000-7461 · Cited by 89
Increased Vulnerability to 3‐Nitropropionic Acid in an Animal Model of Huntington's Disease
Bogdanov, M. B., Ferrante, R. J., Kuemmerle, S., Klivènyi, P., & Beal, M. F. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062642.x · Cited by 88
Wu, H.-Y., Hsu, F., Gleichman, A. J., Baconguis, I., Coulter, D. A., & Lynch, D. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700624200 · Cited by 87
Recruiting Extrasynaptic NMDA Receptors Augments Synaptic Signaling
Harris, A. Z., & Pettit, D. L. (2007) · Journal of Neurophysiology · doi:10.1152/jn.01169.2007 · Cited by 87
Rebec, G., Conroy, S. K., & Barton, S. J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.08.062 · Cited by 86
Neuroprotective Effects of Synaptic Modulation in Huntington's Disease R6/2 Mice
Stack, E. C., Dedeoglu, A., Smith, K. M., Cormier, K., Kubilus, J. K., Bogdanov, M. B., Matson, W. R., Yang, L., Jenkins, B. G., Luthi‐Carter, R., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4318-07.2007 · Cited by 85
Wood, J. D., Macmillan, J., Harper, P. S., Lowenstein, P. R., & Jones, A. L. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.4.481 · Cited by 85
André, V. M., Fisher, Y. E., & Levine, M. S. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00046 · Cited by 84
Self-citationKung, V., Hassam, R., Morton, A. J., & Jones, S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.03.036 · Cited by 81
GPi‐DBS in Huntington's disease: Results on motor function and cognition in a 72‐year‐old case
Fasano, A. A., Mazzone, P. A. M., Piano, C., Quaranta, D., Soleti, F., & Bentivoglio, A. R. (2008) · Movement Disorders · doi:10.1002/mds.22116 · Cited by 81
Steiner, H., & Gerfen, C. R. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00241-3 · Cited by 79
Altered Cortical Glutamate Receptor Function in the R6/2 Model of Huntington's Disease
André, V. M., Cepeda, C., Venegas, Á., Gomez, Y., & Levine, M. S. (2005) · Journal of Neurophysiology · doi:10.1152/jn.01118.2005 · Cited by 78
Self-citationBerríos, G. E., Wagle, A. C., Marková, I. S., Wagle, S. A., Ho, L. W., Rubinsztein, D. C., Whittaker, J., ffrench‐Constant, C., Kershaw, A., Rosser, A., et al. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00257-8 · Cited by 77
Garrett, M. C., & Soares-da-Silva, P. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09283.x · Cited by 75
Cummings, D. M., Cepeda, C., & Levine, M. S. (2010) · ASN NEURO · doi:10.1042/an20100007 · Cited by 74
Self-citationCowan, C. M., Fan, M., Fan, J., Shehadeh, J., Zhang, L. Y. J., Graham, R. K., Hayden, M. R., & Raymond, L. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4619-08.2008 · Cited by 72
Self-citationMultiplicity of glutamate receptor subunits in single striatal neurons: an RNA amplification study.
Ghasemzadeh, M. B., Sharma, S., Surmeier, D. J., Eberwine, J. H., & Chesselet, M. ‐. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09077-7 · Cited by 72
Global cerebral atrophy in early stages of Huntingtonʼs disease: quantitative MRI study
Kassubek, J., Landwehrmeyer, G. B., Ecker, D., Juengling, F. D., Muche, R., Schuller, S., Weindl, A., & Peinemann, A. (2004) · Neuroreport · doi:10.1097/00001756-200402090-00030 · Cited by 71
Christopherson, K. S., Sweeney, N. T., Craven, S. E., Kang, R., El-Husseini, A., & Bredt, D. S. (2003) · Journal of Cell Science · doi:10.1242/jcs.00617 · Cited by 71
Thomas, E. A., Coppola, G., Tang, B., Kuhn, A., Kim, S., Geschwind, D. H., Brown, T. B., Luthi‐Carter, R., & Ehrlich, M. E. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq548 · Cited by 70
Starr, P. A., Kang, G. A., Heath, S., Shimamoto, S. A., & Turner, R. S. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.01.023 · Cited by 69
Changes in striatal dopamine D2 receptor binding in pre‐clinical Huntington’s disease
van Oostrom, J. C. H., Dekker, M., Willemsen, A. T. M., de Jong, B. M., Roos, R. A. C., & Leenders, K. L. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02390.x · Cited by 68
An immunohistochemical investigation of the human neostriatum in huntington's disease
Goto, S., Hirano, A., & Rojas-Corona, R. R. (1989) · Annals of Neurology · doi:10.1002/ana.410250315 · Cited by 66
Wahl, A.-S., Buchthal, B., Rode, F., Bomholt, S. F., Freitag, H. E., Hardingham, G. E., Rønn, L. C. B., & Bading, H. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.018 · Cited by 64
NMDA-stimulated expression of BDNF mRNA in cultured cerebellar granule neurones.
Favaron, M., Manev, R. M., Rimland, J. M., Candeo, P., Beccaro, M., & Manev, H. (1993) · PubMed · Cited by 63
Abnormal cortical synaptic plasticity in a mouse model of Huntington's disease
Cummings, D. M., Milnerwood, A. J., Dallérac, G. M., Vatsavayai, S. C., Hirst, M. C., & Murphy, K. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.10.016 · Cited by 61
Self-citationLee, S., Chu, K., Park, J., Kang, L., Ko, S., Jung, K., & Kim, M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.08.035 · Cited by 59
Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington’s disease
Benn, C., Slow, E., Farrell, L. A., Graham, R. K., Deng, Y., Hayden, M. R., & Cha, J.-H. J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.03.010 · Cited by 59
Complexity and Heterogeneity: What Drives the Ever‐changing Brain in Huntington's Disease?
Rosas, H. D., Salat, D. H., Lee, S. Y., Zaleta, A. K., Hevelone, N. D., & Hersch, S. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.034 · Cited by 59
Jocoy, E. L., André, V. M., Cummings, D. M., Rao, S. P., Wu, N., Ramsey, A. J., Caron, M. G., Cepeda, C., & Levine, M. S. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00028 · Cited by 58
Self-citationHyperdopaminergic Status in Experimental Huntington Disease
Jahanshahi, A., Vlamings, R., Kaya, A. H., Lim, L. W., Janssen, M. L. F., Tan, S. K. H., Visser-Vandewalle, V. E. R. M., Steinbusch, H. W. M., & Temel, Y. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181ee005d · Cited by 53
Petersén, Å., Chase, K. O., Puschban, Z., DiFiglia, M., Brundin, P., & D, N. A. M. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7885 · Cited by 52
Christie, J. M., Jane, D. E., & Monaghan, D. T. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35403-5 · Cited by 47
The neurochemistry of Huntington's chorea
SPOKES, E. G. S. (1981) · Trends in Neurosciences · doi:10.1016/0166-2236(81)90037-0 · Cited by 46
Brown, T. B., Bogush, A. I., & Ehrlich, M. E. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn206 · Cited by 45
Xifró, X., Giralt, A., Saavedra, A., García‐Martínez, J. M., Díaz-Hernández, M., Lucas, J. J., Alberch, J., & Pérez‐Navarro, E. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.08.012 · Cited by 42
Lü, C.-W., Lin, T., & Wang, S. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.05.010 · Cited by 42
Aripiprazole Effects on Psychosis and Chorea in a Patient With Huntington’s Disease
Lin, W., & Chou, Y.-H. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08040503 · Cited by 41
In vivo dopamine release and uptake impairments in rats treated with 3-nitropropionic acid
Kraft, J. C., Osterhaus, G. L., Ortiz, A. N., Garris, P. A., & Johnson, M. A. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.083 · Cited by 38
Cepeda, C., Itri, J. N., Flores‐Hernández, J., Hurst, R. S., Calvert, C. R., & Levine, M. S. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01783.x · Cited by 38
Self-citationRegulation of NMDA Receptors by Kinases and Phosphatases
Salter, M. W., Dong, Y., Kalia, L. V., Liu, X. J., & Pitcher, G. M. (2009) · Europe PMC (PubMed Central) · Cited by 32
Kim, S. H., Thomas, C. A., André, V. M., Cummings, D. M., Cepeda, C., Michael, S. L., & Ehrlich, M. E. (2011) · ASN NEURO · doi:10.1042/an20110009 · Cited by 31
Self-citationHernández‐Espinosa, D., & Morton, A. J. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.03.013 · Cited by 24
The site of termination of afferent fibres on the neurones of the caudate nucleus.
Kemp, J. M. (1970) · PubMed · Cited by 11
Stern, E. A. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00047 · Cited by 10
Calcium Channel Dysfunction in Huntington’s Disease
Cherry, S. (2009) · doi:10.21007/etd.cghs.2009.0051 · Cited by 1
Cited by
Microglia-mediated neuroinflammation in neurodegenerative diseases
Subhramanyam, C. S., Wang, C., Hu, Q., & Dheen, S. T. (2019) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.05.004 · Cited by 870
Extrasynaptic NMDA Receptor Involvement in Central Nervous System Disorders
Parsons, M. P., & Raymond, L. A. (2014) · Neuron · doi:10.1016/j.neuron.2014.03.030 · Cited by 553
Self-citationGlutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration
Andersen, J. V., Markussen, K. H., Jakobsen, E., Schousboe, A., Waagepetersen, H. S., Rosenberg, P. A., & Aldana, B. I. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108719 · Cited by 371
Huntington's disease: underlying molecular mechanisms and emerging concepts
Labbadia, J., & Morimoto, R. I. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.05.003 · Cited by 369
A genetically encoded fluorescent sensor for in vivo imaging of GABA
Marvin, J. S., Shimoda, Y., Magloire, V., Leite, M., Kawashima, T., Jensen, T. P., Kolb, I., Knott, E. L., Novak, O., Podgorski, K., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0471-2 · Cited by 354
Metadata
- Authors
- Raymond, L. A., André, V. M., Cepeda, C., Gladding, C. M., Milnerwood, A. J., & Levine, M. S.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 198
- Pages
- 252-273
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2017901987
- Cited by
- 325
- References
- 297
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.